Roy Amariglio

VP, Orbimed

Lecture title: Investments in Life-Sciences, Current and Future Trends

Roy Amariglio, Ph.D., is a Vice President on the Israel team covering venture capital investments in biotech, medical device and diagnostics companies. Prior to joining OrbiMed, he was a Director of Mergers, Acquisitions and Licensing at Bayer HealthCare where he was responsible for Healthcare transactions. While at Bayer, he held several positions of increasing responsibilities in Oncology Marketing and in Business Development. Dr. Amariglio received his B.A. in Chemistry and Biology from Tel Aviv University and M.Sc. and Ph.D. in Molecular Genetics from the Weizmann Institute in Israel, as well as an M.B.A. in Finance and Healthcare Management from the Wharton School of the University of Pennsylvania.